Canadian Investment Regulatory Organization Trade Resumption - CZZL

Trading resumes in:

Cboe CA Exchange Symbol: CZZL

All Issues: Yes

Resumption (ET): 9:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

News Provided by PR Newswire via QuoteMedia

CZZL:AQL

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced its deepened partnership with Tel Aviv Sourasky Medical Center ("Sourasky Medical Center"). Israel's second-largest public hospital, Sourasky... Keep Reading...

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private... Keep Reading...

Canadian Investment Regulatory Organization Trade Resumption - CZZL

Cizzle Brands Corporation

5 Small-cap Biotech ETFs to Watch

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Latest News

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Interactive Chart

Latest Press Releases

Sirios Resources: Advancing a Multi-million-ounce Gold Project in Québec’s James Bay Region

Tartisan Nickel: Working Towards a Feasibility Study and Production Decision at the Kenbridge Nickel Deposit

TomaGold: Advancing a District-scale Gold and Base Metal Portfolio in Québec’s Chibougamau Mining Camp

Prismo Metals Advances to Drilling at Historic Silver King Silver Project with Permit Approval and Contractor Engagement

Related News

Sirios Resources: Advancing a Multi-million-ounce Gold Project in Québec’s James Bay Region

Tartisan Nickel: Working Towards a Feasibility Study and Production Decision at the Kenbridge Nickel Deposit

TomaGold: Advancing a District-scale Gold and Base Metal Portfolio in Québec’s Chibougamau Mining Camp

Prismo Metals Advances to Drilling at Historic Silver King Silver Project with Permit Approval and Contractor Engagement

Prismo Metals Advances to Drilling at Historic Silver King Silver Project with Permit Approval and Contractor Engagement

Purification testwork exceeds target specifications

Drilling Commences at Lo Herma ISR Uranium Project

TOP STOCKS